CAR T-cells are becoming somewhat of a household name, but a new phase I trial is, for the first time, using CAR ‘NKT’ cells, featuring genetic modification of a different immune cell, natural killer cells. Natural killer T-cells have long been known to be important in mediating the immune system’s response to cancer, targeting both tumor cells […]

Despite the number and proportion of women obtaining STEM degrees in the last few decades increasing considerably, representation in leadership positions in their respective fields has been fairly stagnant. According to the National Institutes of Health, “Women comprise half of the employees in the pharmaceutical and medical industries, but available data suggest they represent about 17% […]

Cancer therapy development has advanced to researching targeted immunotherapies and are moving into gene-specific therapies.  Some companies, however, are focusing on reviving cytotoxic therapies that were too toxic for patients when administered generally. These companies are developing targeted transportation mechanisms to deliver cytotoxic release at tumor cells while minimizing overall toxicity to patients. Bill Newell, Chief […]